Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-22

Clinical Trial Update: First-Line Treatment for HIV-2 [Phase 2, Phase 3]

View source ↗

Summary

A first-line treatment study for HIV-2 has completed Phase 2/Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-2 Infection | Phase 2, Phase 3 | Status: COMPLETED